I'd rather not be alone in a room with a male provider — is that respected?

Yes. Always. We ask about staff and room preferences during intake and accommodate without explanation required. This is standard trauma-informed care, not a special request. If we cannot meet a preference for a given session, we will tell you that up front so you can decide whether to reschedule.

Do I have to disclose what happened to me?

No. We screen for medical safety and contraindications, not for trauma narrative. You do not need to tell us what happened, when, or by whom. Disclosure work, if you choose to do it, belongs with a trauma therapist or VA MST coordinator on a separate timeline from infusion.

Will ketamine bring up memories I've worked hard to bury?

Honestly, the dissociative experience is variable and partly unpredictable. Some patients have memory-adjacent material surface; others do not. This is one of the reasons an integration therapist matters, and one of the reasons we encourage MST patients to have that support already in place before starting a course rather than after.

Does the VA cover ketamine for MST?

VA covers Spravato (esketamine) within its treatment-resistant depression criteria, and some VA facilities offer IV ketamine within research or specialty programs. Off-label IV ketamine in the community is generally not covered. We recommend asking your VA mental health team and MST coordinator what is available before paying out of pocket.

Is combat PTSD or MST harder to treat?

Different, not strictly harder. MST adds shame, betrayal-trauma layers, and an institutional context that changes the relational frame of treatment. Combat PTSD often carries different layers — moral injury, survivor guilt, hyperarousal tied to specific environments. Both respond to careful, trauma-informed care; the setup that makes care careful is not the same.

Combat PTSD vs. Military Sexual Trauma: Why Ketamine Treatment Isn't One-Size-Fits-All

What VA data actually say about MST and PTSD prevalence

Military sexual trauma is a VA-defined term covering sexual assault and threatening, repeated sexual harassment experienced during military service. The VA screens every veteran who enters its care, and the screening data have been published consistently for more than a decade. Two numbers tell the basic story.

Roughly 1 in 3 women and 1 in 50 men in VA care screen positive for MST, according to figures reported by Rachel Kimerling and colleagues at the VA National Center for PTSD and consolidated in VA fact sheets drawing on data from the early 2000s onward. Because men outnumber women in the veteran population, the absolute number of men affected is substantial even at a much lower rate. MST is not a women-only issue, and treatment programs that frame it that way miss patients who are already isolated.

The link to PTSD is the more striking statistic. Across Kimerling's published analyses of VA data, veterans who screen positive for MST have substantially elevated odds of meeting PTSD criteria—adjusted odds ratios above 8 for women in some samples. MST is, on the available evidence, one of the most PTSD-generating exposures the VA tracks. That has implications for how a clinic should set up an infusion course for an MST veteran versus a combat veteran, even when the diagnostic label on the chart reads the same.

For the basics on how PTSD presents and what the treatment landscape looks like, our PTSD condition page covers ground we will not repeat here. This article is about a narrower question: how the same diagnosis can hide two different clinical pictures, and what that asks of a clinic offering ketamine.

Symptom profile differences—combat vs. MST

Combat PTSD and MST share core PTSD criteria—intrusion, avoidance, negative cognitions, hyperarousal—but the texture is often different in ways that matter clinically.

Combat PTSD frequently centers on hyperarousal tied to specific environments: crowds, traffic, doorways, the sound of helicopters, fireworks at the wrong time of year. Moral injury and survivor guilt are common companions. Sleep is fragmented around dreams of specific incidents. The trauma often happened in a context the veteran was trained for, alongside people they trusted, and the institutional response to it has typically been validating rather than adversarial.

MST-related PTSD tends to carry a different signature. Shame and self-blame are heavier. Dissociation is more common. Trust ruptures are not just interpersonal but institutional—the assault often happened within the chain of command, the reporting process may have re-traumatized, and the institution that is now offering treatment may be the same one that mishandled the original report. Avoidance frequently extends to medical settings themselves. Many MST survivors have a history of canceling appointments because something in the room—a male provider, a closed door, a particular kind of consent paperwork—crossed an invisible line.

This is not an absolute split. Some combat veterans carry betrayal trauma; some MST survivors describe their dominant symptom as hyperarousal rather than shame. But the modal profile is different enough that a one-size template fails one or both groups. For veterans whose presentation includes the relational and developmental layering common in complex PTSD, the considerations get heavier still.

Why institutional trust matters in MST treatment

Trauma-informed care is a phrase that gets used loosely. In the MST context it has a specific meaning: the patient should never be in the position of having to absorb friction from the system in order to receive care. Choice, control, and predictability are not nice-to-haves; they are part of the treatment.

What this looks like in practice is mundane. The patient knows in advance who will be in the room. They know what the room looks like. They know the door can be left ajar or fully closed at their preference. They know they will not be touched without being told first. They know that if a preference cannot be accommodated for a given session, that will be disclosed in advance rather than at the IV pole.

For combat PTSD patients, much of this is still good practice but rarely load-bearing. For MST patients, getting it wrong on the first session can end the course. We have heard from patients who left other clinics not because the medicine failed but because something in the setup cost them more than they could pay—a male provider they had not been told about, a consent form full of language they could not read calmly, a waiting room with no clear path out.

What Feder 2021 supports—and where it stops

The strongest randomized-controlled evidence for IV ketamine in chronic PTSD is Adriana Feder and colleagues' 2021 paper in the American Journal of Psychiatry. The trial randomized 30 patients with chronic PTSD to six infusions of either ketamine or midazolam over two weeks. The ketamine arm showed significantly greater reduction on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at the two-week endpoint, and the response held longer than what single-infusion studies had previously shown.

That result moved the field. It is a real signal. But it is important to be precise about what the trial does and does not say for the population this article is about. The Feder 2021 trial enrolled chronic PTSD patients across multiple trauma types and was not stratified by combat exposure versus military sexual trauma. The findings support repeated-dose IV ketamine as a plausible option for chronic PTSD broadly. They do not, on their own, tell us whether response rates or relapse curves differ between combat-PTSD and MST-PTSD subgroups. To our knowledge, that head-to-head stratification has not been done in a randomized trial.

Ketamine is FDA-approved as an anesthetic; its use for PTSD—whether the trauma is combat, sexual, or otherwise—is off-label. Spravato (esketamine) is FDA-approved for treatment-resistant depression and for major depressive disorder with acute suicidal ideation, not for PTSD. The 2023 VA/DoD Clinical Practice Guideline for the Management of PTSD continues to place trauma-focused psychotherapies—Cognitive Processing Therapy, Prolonged Exposure, and EMDR—as first-line, with SSRIs and SNRIs as established pharmacotherapy. The 2023 guideline does not recommend ketamine as a routine treatment for PTSD itself; it suggests against ketamine for the PTSD diagnosis, while leaving room for use in TRD comorbidity per the VA/DoD MDD guideline. Any ketamine course in a PTSD context belongs alongside, not in place of, trauma-focused therapy.

The honest framing for veterans considering a course is this: the mechanism is real, the data are encouraging, and the evidence base is still narrower than the marketing language used by some clinics suggests. We default to that honesty when we talk to families, and we default to it for ourselves.

How a careful infusion is set up differently for an MST patient

The medical protocol—dose, monitoring, consent, vital signs—does not change between combat PTSD and MST. The choreography around it does. A few of the adjustments we make for MST patients when requested:

Staff sex preference, asked early. If a patient prefers female staff in the room, that goes on the intake before scheduling so we can hold the right slot. Marla Peterson, CRNA, oversees every infusion at our clinic; the question is about who else is or is not present and at what point.
Room and door preferences. Some patients want the door fully closed; others need it visibly cracked. Some want the lights lower than our default; some want them brighter. None of this is unusual to ask.
Touch and physical setup discussed before the IV. The IV start, the blood pressure cuff, the pulse oximeter clip—each gets named before it happens. For patients with assault history, a surprise touch can derail an entire session.
Music and headphones. A patient-chosen playlist on noise-isolating headphones is standard practice for ketamine, and especially helpful when the room is shared acoustically with a hallway. Our note on ketamine music and playlists covers what tends to work.
An exit plan. The patient knows how to signal that they want to stop, slow down, or be left alone for a moment. Knowing the brake works is part of why patients can let go enough for the medicine to do anything.
Integration support arranged before the first infusion. For reasons covered in our piece on finding an integration therapist in Tennessee, MST patients in particular benefit from having a trauma-informed therapist already in place before starting—not scrambling for one mid-course if material surfaces.
Permission to cry, dissociate, or stay quiet. The dissociative experience is variable, and our note on whether you can cry during ketamine addresses what is normal and what is not.

Coordinating with VA, Vet Centers, and trauma-informed therapists

Music City Ketamine is a community clinic in Franklin, Tennessee. We are not a VA facility, and we are not a substitute for one. Most of the veterans we see—whether the trauma is combat or MST—benefit from staying connected to VA mental health, a Vet Center, or a community trauma therapist while they pursue an off-label infusion course with us. The VA's MST coordinators are a particularly under-used resource; every VA facility has at least one, and the role exists specifically to help survivors navigate care without re-injury.

For broader context on veterans-specific issues we cover the territory in our ketamine for veterans overview and our companion piece on ketamine for first responders, who often share overlapping presentations. Our veterans page describes how we structure intake. The general PTSD landscape—mechanism, what evidence supports, how this differs from antidepressants—is in our ketamine for PTSD article.

If you are already in CPT, PE, or EMDR with a therapist you trust, that work is the first-line treatment per the VA/DoD guideline. Ketamine, when it helps, often helps by widening the window in which therapeutic work can land. We coordinate when patients want us to, with their written permission, and we stay in our lane otherwise.

What we ask before booking

Cost is a real factor for veterans whose VA benefits do not extend to off-label community ketamine. At Music City Ketamine, sessions are $475 each. We do not invent prices, we do not bundle in costs that are not relevant, and we will tell you in plain language what a typical course looks like before you commit to anything. For some veterans, that conversation ends with us recommending that they pursue VA Spravato or a VA research protocol first; for others, it ends with a scheduled intake.

A few questions we want to surface before a first session, especially for MST patients:

Is there a current trauma-informed therapist or VA mental health clinician you are working with, and are you comfortable telling them you are exploring ketamine?
Are there specific staff, room, or procedural preferences we should know up front?
What medications are you currently taking, and who is your prescribing provider? We never recommend stopping or changing psychiatric medications; that conversation belongs with your prescriber.
Are there safety concerns—current suicidal ideation, recent destabilization, active substance use—that should change the timing or setting of a course?

We hedge our claims because the data ask us to. Studies indicate that IV ketamine can produce meaningful symptom reduction in chronic PTSD; research suggests that the response is faster than with SSRIs and that some patients see relief that lasts weeks rather than days. We do not promise results, we do not market this as a fix, and we do not pretend the field has settled questions it has not. What we can offer is a careful setup, a clinical standard appropriate to the medicine, and the time to decide whether this fits your situation.